Red Light Intervention on Myopic Progression

• Status: Recruiting
• Trial end date: 2024-06-30
• Target enrollment: 0
• Participant gender: All

Summary

To explore the effectiveness of using repeated low-level red-light therapy to slow myopia progression.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Eye Disease Prevention and Treatment Center
• Treatments: Atropine

Criteria

Inclusion Criteria:

1. Age at enrolment: 6-12 years;

2. At least one eye with spherical equivalent refractions (SERs): -1.00 to -5.00 diopters (D), and stigmatism of 1.50 D or less;

3. Anisometropia of 1.5 D or less;

4. The BCVA of distant vision is at least 0.8;

5. Myopia progressed more than 0.5D in the past year;

6. Have normal thinking and language communication skills, and be able to actively cooperate with the treatment as required;

7. Written informed consent of guardian and child.

Exclusion Criteria:

1. Strabismus, amblyopia or other ocular abnormalities;

2. Other systemic abnormalities;

3. Prior treatment of myopia control in 6 months, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, etc in either eye;

4. Atropine allergy;

5. Other situations that not suitable for participating in the trial as judged by the researcher.